About
Technology
Therapeutics
Partnering
Careers
Newsroom
Contact
Twitter
Linkedin
info@bighatbio.com
About
About
Technology
Technology
Therapeutics
Therapeutics
Partnering
Partnering
Careers
Careers
Newsroom
Newsroom
Twitter
Twitter
Linkedin
Linkedin
Contact Us
The Latest
Newsroom
All
Announcements
Press
Publications
Presentations
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
7.20.2022
BigHat raises $75M Series B
Announcements
2.10.2021
BigHat raises $19M Series A
Announcements
Recent Posts
8.2.2023
BigHat’s CSO on Biocom CA’s Lifelines Podcast
Announcements
6.1.2023
BigHat Appoints John Corbin, PhD as Chief Development Officer
Announcements
12.21.2022
BigHat Year in Review 2022
Announcements
11.29.2022
BigHat Biosciences Announces Research Collaboration with Merck
Announcements
9.29.2022
BigHat Biosciences validates best-in-class security posture with spotless SOC2 audit
Announcements
7.20.2022
BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies
Announcements
6.23.2022
BigHat’s CSO and VP Engineering speaking at AWS Summit San Francisco
Announcements
5.11.2022
BigHat Biosciences Appoints Rob Chess, Serial Entrepreneur, to its Board of Directors
Announcements
3.28.2022
BigHat Biosciences Completes Its Acquisition of Frugi Biotechnology
Announcements
3.8.2022
Luminaries Rob Chess, Mark Pegram and Michael Jewett join BigHat’s Advisory Board
Announcements
3.1.2022
BigHat in Pharma’s Almanac Q1 2022 Issue
Announcements
2.23.2022
BigHat’s CEO and CSO on BIOS Builders podcast
Announcements
1 / 4
Next
© BigHat Bio 2023